Loading...
Market
Third COVID-19 vaccine dose recommended for seniors by end of 2025?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from major health organizations like WHO, CDC, or FDA
Story
CDC Recommends Second 2024-2025 COVID-19 Vaccine Dose for Seniors and Immunocompromised
Oct 24, 2024, 03:23 PM
The Centers for Disease Control and Prevention (CDC) has recommended a second dose of the 2024-2025 COVID-19 vaccine for individuals aged 65 and older, as well as those with moderately to severely weakened immune systems. This recommendation, made by the Advisory Committee on Immunization Practices (ACIP) on October 23, 2024, aims to enhance protection for these vulnerable groups. The CDC advises that the second dose should be administered six months after the initial dose, establishing a 6-month vaccine cadence. The policy is specific to the 2024-2025 period and includes provisions for immunocompromised individuals to receive additional doses in consultation with their clinicians.
View original story
Similar markets
Less than 40% • 25%
40% to 60% • 25%
60% to 80% • 25%
More than 80% • 25%
Increased availability • 25%
Government incentives • 25%
Public health campaigns • 25%
Other • 25%
Less than 40% • 25%
40% to 50% • 25%
51% to 60% • 25%
More than 60% • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
